🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT05920252
Recruiting Not applicable

A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide

NCT05920252 · tracked via the Priya Life Science USA tracker
Sponsor
Ksana Health
Phase
Not applicable
Started
2024-08-14
Last updated
2026-03-04

Condition(s) studied

SuicideMental Health DisorderAnhedonia

Investigational drug(s) / intervention(s)

ViraTreatment as Usual (TAU)

Vira: Intensive outpatient DBT supported by the Vira platform. The Vira app is installed on the patient's smartphone. The app passively collects data from phone sensors (i.e., measures of physical activity, sleep patterns, mobility, and language patterns reflecting mood states and cognition) that are indicative of risk-relevant behavioral patterns and psychological states. It also prompts users to answer a daily check in question. Mobile sensing data are processed to provide an automated assessment of the user's functioning. Patients will be asked to use Vira for the duration of their intensive outpatient treatment. Patients' use of the Vira app is supported by practitioners, who can schedule just-in-time reminders (i.e., "nudges") to arrive in the user's phone at scheduled times to support their behavior change plan and DBT treatment. The Vira Platform therefore integrates mobile sensing, self-report assessment, and just-in-time nudges and notifications into the practitioner's workflow.

Treatment as Usual (TAU): Intensive outpatient DBT + EARS app (passive data monitoring software)

Study summary

Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death among youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to provide a unique understanding of risk factors, including psychological distress, anhedonia and behavioral withdrawal, and sleep disturbance among high-risk individuals. This project aims to enhance the effectiveness of the delivery of preventative health care to youth at risk for suicide by developing a comprehensive digital platform that allows practitioners to integrate mobile sensing data and HIPAA-compliant client communication tools into their management of these young people.

Eligibility

Sex
ALL
Min age
13 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Written informed assent from adolescents ages 13-17 years old and permission from legal guardians, or consent from adolescents age 18 years old. * Receiving treatment at the Intensive Adolescent and Family DBT Pgogram * 13-18 years old * Owns a personal smartphone (Android or iPhone 7+) * Fluent in English Exclusion Criteria: * Adolescents who require a higher level of care (i.e., are not admitted to the Intensive Outpatient DBT program) * Adolescents who are receiving treatment at the Intensive Adolescent and Family DBT program and have already been assigned a clinician

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Columbia University New York New York Recruiting

More Ksana Health trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05920252 on ClinicalTrials.gov ↗ ← All trials in the USA